Serguei M. Liachenko, MD, PhD

Director of Bioimaging
US FDA/NCTR
Jefferson, Arkansas, United States

Presentation(s):

• T2-MRI Mapping and Fluidic Neurofilament Light (NfL) as a Minimally Invasive Correlate of Central Nervous System (CNS) Toxicity in a Cuprizone Model: A Biomarker Study (P121)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT

• Biomarkers for CNS Toxicity—From Bench to Bedside (S07)

  Tuesday, November 19, 2024
  9:00 AM - 12:00 PM CT

• In Vivo Imaging Biomarkers of Neurotoxicity (S07-4)

  Tuesday, November 19, 2024
  10:45 AM - 11:15 AM CT